- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01316627
Study of Patients With Body Image Issues Treated With 2 Different Behavioral Interventions (BDD)
Crooked Mirror Externalization Therapy for Body Dysmorphic Disorder
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Screening: Potential subjects who call the Westwood Institute for Anxiety Disorders, Inc. requesting treatment will be given details about the study by a trained research assistant. Any questions that potential subjects have will be addressed. If subjects are interested, they will be invited to be screened to determine whether they meet initial criteria for the study. Potential subjects will be told that all information gathered during screening is confidential. If a potential subject does not meet inclusion criteria, or decides not to participate, the screening information will be destroyed. This information is then passed to the study physician, Dr. Kagan, who will contact potential subjects to make an appointment for further evaluation. Potential subjects are encouraged to discuss their possible participation in this study with their physician, therapist, and/or family members. They are also encouraged to write down questions they would like to ask the study physician upon further evaluation. This screening process is done as part of the research process.
Further Evaluation: After the initial telephone screening, potential subjects will meet with the principal investigator, Dr. Eda Gorbis, who will ask the subject to sign an informed consent form (ICF). The research procedures and treatment will be described in detail to the subject and any questions will be answered by the principal investigator. The ICF will be signed by the subject and the principal investigator, agreeing to those procedures in the study that are considered research, acknowledging that their participation is voluntary, and that they have been informed of the risks and benefits of the study. Research procedures include cognitive testing, standardized rating scales, and clinical assessment questionnaires discussed below.
When the ICF is signed, the potential subjects will meet with the study physician, Dr. Kagan, for a comprehensive psychiatric evaluation and physical assessment to confirm a primary diagnosis of BDD according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV), and identify any confounding comorbidity, physical health, or medication issues which may or may not preclude their participation in treatment. According to subjects' self-report, those who are currently on medication for their BDD must have a regular prescribing physician who can continue prescribing their medication.
Upon confirmation of inclusion into the study, subjects will then be given appointments for cognitive testing and further clinical assessments by the study independent evaluator. The Mini International Neuropsychiatric Interview for DSM-IV (M.I.N.I.; Sheehan & Lecrubier et al., 1998) will be used to determine comorbid disorders that are excluded from the study, which will take approximately 45 minutes to complete. The Wechsler Adult Intelligence Scale - Third Edition (WAIS-III; Wechsler 1997), which is an instrument that assesses verbal and nonverbal intellectual functioning, will be used to determine subjects' cognitive capacity, and will take approximately 90-120 minutes to complete.
Assessment Instruments: One week prior to treatment, subjects will be administered a battery of clinical rating scales and questionnaires to determine the severity of their BDD and any secondary symptoms. This same assessment battery will be given immediately following treatment to determine the level of efficacy of each of the two treatment groups. These scales include the Yale-Brown Obsessive-Compulsive Scale Modified for BDD (BDD-YBOCS), Body Dysmorphic Disorder Examination-Self Report (BDDE-SR), BDD Diagnostic Module (BDDDM), Y-BOCS Symptom Checklist, Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), Hamilton Rating Scale for Depression (Ham-D), Hamilton Anxiety Rating Scale (HARS), Fixity of Beliefs Questionnaire, Global Assessment of Functioning (GAF), NIMH Global Obsessive-compulsive Scale, Brown Assessment of Beliefs Scale (BABS), Obsessive-Compulsive Inventory (OCI), Obsessive-Compulsive Rating Scale (OCON), Fear Survey Schedule (FSS), and the Revised Willoughby Questionnaire. These will take approximately 90-120 minutes to complete.
Randomization: Following assessment, subjects will be pseudo-randomized into either the mirror retraining treatment group or the crooked mirror treatment group. Pseudo-randomization means that subjects will first be assigned to one of the two groups randomly, then group membership will be remixed if needed to assure that there is no significant between-group difference in pretreatment BDD-YBOCS scores. If possible, groups will also be matched for age and gender.
Intensive Cognitive-Behavioral Therapy: After subjects complete the pre-treatment assessments, the study therapist will meet with participants to design their treatment program. Treatment will be conducted every day for 15 days, Monday through Friday, for 90-minute sessions. In addition, as a part of therapy, subjects will complete homework assignments daily. Intensive CBT for BDD is done in the form of Exposure and Response Prevention (ERP) with either the mirror retraining method or the crooked mirror externalization therapy. This involves prolonged and repeated exposures to images of the perceived defects, and prevention of ritualistic behavior (e.g., camouflaging with cosmetics, skin-picking, etc.).
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Contact
- Name: Eda Gorbis, PhD, LMFT
- Phone Number: 310-443-0031
- Email: edagorbis@yahoo.com
Study Locations
-
-
California
-
Los Angeles, California, United States, 90024
- Recruiting
- Westwood Institute for Anxiety Disorders, Inc.
-
Contact:
- Eda Gorbis, PhD, LMFT
- Phone Number: 310-443-0031
- Email: edagorbis@yahoo.com
-
Sub-Investigator:
- Jenny C Yip, PsyD
-
Principal Investigator:
- Eda Gorbis, PhD, LMFT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18-60
- Meets DSM-IV criteria for BDD
- Baseline 12-item BDD-YBOCS score >15
- Baseline 33-item BDDE score > 99
- Baseline 3-item BDDDM score > 9
- IQ > 90
- English-speaking
- No changes in psychotropic medication during or 12 weeks prior to study
Exclusion Criteria:
- No medical contraindications
- No co-morbid psychiatric contraindications (psychosis, bipolar disorder, Tourette's or other tic disorder, panic disorder, PTSD, ADHD, anorexia nervosa, bulimia)
- Current suicidality
- Primary diagnosis of OCD, depression, or substance abuse
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Crooked Mirror Externalization Therapy
Of recent, the "crooked mirror" externalization therapy, developed by Dr. Eda Gorbis, has been put to use with much success (Gorbis 2004).
This method involves the use of crooked or "fun house" mirrors made from highly reflective surfaces that can be bent in different directions, which distort and exaggerate the patient's perceived defects (Gorbis 2005).
In turn, this process externalizes or reverses the patient's internalized distorted body image, and allows the patient to habituate to the reflection of the imagined defect that is even more distorted than the internalized image (Rosen et al. 1995).
|
After subjects complete the pre-treatment assessments, the study therapist will meet with participants to design their treatment program.
Treatment will be conducted every day for 15 days, Monday through Friday, for 90-minute sessions.
In addition, as a part of therapy, subjects will complete homework assignments daily.
Intensive CBT for BDD is done in the form of Exposure and Response Prevention (ERP) with either the mirror retraining method or the crooked mirror externalization therapy.
This involves prolonged and repeated exposures to images of the perceived defects, and prevention of ritualistic behavior (e.g., camouflaging with cosmetics, skin-picking, etc.).
Other Names:
|
Active Comparator: Mirror Retraining Method
In treating BDD, the cognitive-behavioral technique, "mirror retraining," uses ordinary and/or magnifying mirrors to amplify the supposed defect, which teaches patients to see their appearance in a more holistic way.
Since BDD patients tend to only focus on their perceived flaws when looking in the mirror, and tend to think about their flaws in negative terms, in mirror retraining, patients learn how to change their negative evaluations of their appearance into more objective and nonjudgmental descriptions.
Generally, this method is designed to intentionally exaggerate anxiety regarding appearance concerns through exposures with mirrors.
However, using exclusively ordinary and/or magnifying mirrors does not address the internal distorted image that many patients with BDD experience (Rosen et al. 1995, Osman et al. 2004, Veale 2004).
|
After subjects complete the pre-treatment assessments, the study therapist will meet with participants to design their treatment program.
Treatment will be conducted every day for 15 days, Monday through Friday, for 90-minute sessions.
In addition, as a part of therapy, subjects will complete homework assignments daily.
Intensive CBT for BDD is done in the form of Exposure and Response Prevention (ERP) with either the mirror retraining method or the crooked mirror externalization therapy.
This involves prolonged and repeated exposures to images of the perceived defects, and prevention of ritualistic behavior (e.g., camouflaging with cosmetics, skin-picking, etc.).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measure of change in the presence and severity of BDD before and after treatment
Time Frame: Day 1 and at 1 month
|
Body Dysmorphic Disorder Modification of the Y-BOCS (BDD-YBOCS); Phillips et al. 1997: A 12-item questionnaire designed to assess for the presence and severity of BDD symptoms.
|
Day 1 and at 1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measure of change in the presence and type of BDD symptoms before and after treatment
Time Frame: Day 1 and at 1 month
|
Body Dysmorphic Disorder Examination - Self Report (BDDE-SR); Rosen & Reiter 1996; Rosen & Ramirez 1998: A self-report questionnaire that assesses for preoccupation with and negative evaluation of appearance, self-consciousness, embarrassment, excessive importance given to appearance in self-evaluation, avoidance of activities, body camouflaging, and body checking.
|
Day 1 and at 1 month
|
Collaborators and Investigators
Investigators
- Principal Investigator: Eda Gorbis, PhD, LMFT, UCLA - DEPARTMENT OF PSYCHIATRY/BIOBEHAVIORAL SCIENCES
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB#G06-05-061-04
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Dysmorphic Disorders
-
Centre for Addiction and Mental HealthUniversity Health Network, TorontoRecruiting
-
Koa Health B.V.Massachusetts General HospitalActive, not recruitingBody Dysmorphic DisordersUnited States
-
Florida State UniversityCompletedBody Dysmorphic DisorderUnited States
-
Massachusetts General HospitalCompletedBody Dysmorphic DisorderUnited States
-
Karolinska InstitutetVastra Gotaland Region; Region Skane; Region StockholmRecruitingBody Dysmorphic DisordersSweden
-
Massachusetts General HospitalTelefónica S.A.CompletedBody Dysmorphic DisordersUnited States
-
Icahn School of Medicine at Mount SinaiTerminated
-
Institute of Psychiatry, LondonCompletedBody Dysmorphic DisorderUnited Kingdom
-
Massachusetts General HospitalCompleted
-
York UniversityRecruitingBody Image Disturbance | Body Dysmorphic DisorderCanada
Clinical Trials on Crooked Mirror Externalization Therapy
-
The Hong Kong Polytechnic UniversityNational University, Singapore; University of CanterburyNot yet recruiting
-
Olga Del Pozo BlancoHospital Universitario La Fe; University Rovira i VirgiliCompletedCarpal Tunnel SyndromeSpain
-
Istanbul Medipol University HospitalCompleted
-
CEU San Pablo UniversityCompleted
-
Kaohsiung Medical University Chung-Ho Memorial...Recruiting
-
The Hong Kong Polytechnic UniversityTung Wah Hospital; Guangdong 999 Brain HospitalCompletedThe Effects of Mirror Therapy on Patients With Unilateral Neglect After Stroke
-
Universitat Internacional de CatalunyaEnrolling by invitationHemiplegic Cerebral Palsy | Mirror Movement TherapySpain
-
Seoul National University HospitalSeoul National UniversityCompleted
-
Thomas More University of Applied SciencesRevalidatieziekenhuis RevArte; To Walk Again REVAlution CenterCompleted
-
Chang Gung Memorial HospitalRecruiting